Novavax (NVAX) News Today $5.86 +0.43 (+7.92%) Closing price 04/11/2025 04:00 PM EasternExtended Trading$5.82 -0.04 (-0.60%) As of 04/11/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Novavax (NVAX) Stock Plunges Amid Approval DelayApril 13 at 3:12 PM | gurufocus.comTrexquant Investment LP Sells 516,572 Shares of Novavax, Inc. (NASDAQ:NVAX)Trexquant Investment LP cut its stake in shares of Novavax, Inc. (NASDAQ:NVAX - Free Report) by 77.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 150,085 shares of the biopharmaceutical company's stockApril 13 at 4:46 AM | marketbeat.comTraders Buy High Volume of Novavax Call Options (NASDAQ:NVAX)April 12 at 1:13 AM | americanbankingnews.comNovavax says ‘no official response’ from FDA on BLA status for COVID shotApril 11 at 9:01 AM | markets.businessinsider.comNovavax: Regulatory Uncertainty Creates Risk And Opportunity For Beaten-Down Vaccine DeveloperApril 11 at 8:54 AM | seekingalpha.comNovavax Retail Traders Rally In Defense After RFK Jr.'s COVID-19 Vaccine Skepticism Sends Stock TumblingApril 11 at 4:00 AM | msn.comNovavax slides after RFK Jr. casts doubts about COVID vaccineApril 10 at 5:58 PM | markets.businessinsider.comNovavax shares tumble after U.S. health secretary raises concerns over COVID shot's efficacyApril 10 at 3:18 PM | investing.comNovavax shares tumble after U.S. health secretary raises concerns over COVID shot's efficacyApril 10 at 3:02 PM | reuters.comNovavax stock tumbles on HHS comments about vaccineApril 10 at 12:58 PM | investing.comNovavax (NVAX) Faces Setback Amid COVID Vaccine Approval DelayApril 10 at 12:06 PM | gurufocus.comNovavax (NVAX) Faces Stock Drop Amid FDA Vaccine Approval Delay | MRNA Stock NewsApril 10 at 12:06 PM | gurufocus.comNovavax in selloff after RFK Jr.’s comments on COVID vaccineApril 10 at 10:28 AM | seekingalpha.comNovavax, Inc. (NASDAQ:NVAX) Shares Purchased by Vanguard Group Inc.Vanguard Group Inc. increased its position in shares of Novavax, Inc. (NASDAQ:NVAX - Free Report) by 1.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 15,726,250 shares of the biopharmaceutical company's stock after buying aApril 10 at 3:32 AM | marketbeat.comNovavax (NasdaqGS:NVAX) Announces Leadership Change With New Board AppointmentsApril 10 at 2:06 AM | finance.yahoo.comExodusPoint Capital Management LP Takes $2.69 Million Position in Novavax, Inc. (NASDAQ:NVAX)ExodusPoint Capital Management LP purchased a new position in shares of Novavax, Inc. (NASDAQ:NVAX - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 334,146 shares of the biopharmaceutical company's stocApril 9, 2025 | marketbeat.com67,644 Shares in Novavax, Inc. (NASDAQ:NVAX) Bought by Raymond James Financial Inc.Raymond James Financial Inc. purchased a new position in shares of Novavax, Inc. (NASDAQ:NVAX - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 67,644 shares of the biopharmaceutical company's stock, valuApril 9, 2025 | marketbeat.com2 Beaten-Down Stocks That Still Aren't Worth BuyingApril 8, 2025 | fool.comNovavax (NASDAQ:NVAX) Stock Price Up 3.8% - Time to Buy?Novavax (NASDAQ:NVAX) Trading Up 3.8% - Still a Buy?April 6, 2025 | marketbeat.comAnalysts Set Novavax, Inc. (NASDAQ:NVAX) Price Target at $18.00April 6, 2025 | americanbankingnews.comNovavax’s Covid vaccine delayed in FDA reviewApril 6, 2025 | bizjournals.comNovavax, Inc. (NVAX): Among Unstoppable Stocks That Could Double Your MoneyApril 5, 2025 | msn.comFDA delays full approval of Novavax Covid-19 vaccine even though it was on track for clearanceApril 4, 2025 | msn.comNovavax Covid vaccine unlikely to be approved soon, WSJ saysApril 4, 2025 | markets.businessinsider.comFDA delay on Novavax vaccine approval could be bellwether for vaccine sector: BofASApril 4, 2025 | msn.comNovavax, Inc. (NASDAQ:NVAX) Receives Consensus Recommendation of "Hold" from AnalystsNovavax, Inc. (NASDAQ:NVAX - Get Free Report) has been assigned an average recommendation of "Hold" from the seven analysts that are covering the company, Marketbeat reports. One analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and four have assignedApril 4, 2025 | marketbeat.comNovavax’s Regulatory Uncertainty and Market Potential: Hold Rating MaintainedApril 3, 2025 | tipranks.comNovavax believes BLA ‘ready for approval,’ waiting on action from FDAApril 3, 2025 | markets.businessinsider.comNovavax put volume heavy and directionally bearishApril 3, 2025 | markets.businessinsider.comNovavax falls 4% to $5.76 after WSJ report on unlikely approvalApril 3, 2025 | markets.businessinsider.comNovavax set to snap six days of losses as shares trade in greenApril 2, 2025 | msn.comNovavax (NVAX) Stock Climbs Amid FDA Approval Delay for COVID-19 VaccineApril 2, 2025 | gurufocus.comFDA Delays Full Approval Decision On Novavax's COVID-19 VaccineApril 2, 2025 | benzinga.comUS FDA misses deadline for decision on Novavax's COVID-19 vaccineApril 2, 2025 | investing.comNovavax shares fall after FDA delays vaccine approvalApril 2, 2025 | au.investing.comFDA Misses Deadline for Covid-19 Vaccine DecisionApril 2, 2025 | msn.comNovavax (NasdaqGS:NVAX) Sees 21% Weekly Drop As Leadership Changes Shake MarketApril 2, 2025 | finance.yahoo.comNovavax bid for full approval of COVID vaccine stymied by FDA - reportApril 2, 2025 | msn.comFDA misses deadline for decision on Novavax's COVID-19 vaccine, source saysApril 2, 2025 | msn.comFDA misses deadline for decision on Novavax's COVID-19 vaccine, WSJ reportsApril 2, 2025 | reuters.comNovavax (NASDAQ:NVAX) Shares Gap Down - Here's WhyNovavax (NASDAQ:NVAX) Shares Gap Down - Here's WhyApril 1, 2025 | marketbeat.comModerna shares drop amid FDA leadership changeMarch 31, 2025 | finance.yahoo.comModerna, Novavax Stocks Fall After Top FDA Vaccine Official Forced OutMarch 31, 2025 | wsj.comDrugmakers face market turmoil following FDA shakeup and Trump health overhaulMarch 31, 2025 | usatoday.comModerna and Novavax shares plunge after key FDA official steps down, citing discord with RFK Jr. who he says ‘wishes subservient confirmation of his misinformation and lies’March 31, 2025 | fortune.comModerna, Novavax Shares Are Tumbling Monday: What's Going On?March 31, 2025 | benzinga.comVaccine stocks fall after key FDA official resigns in protest of RFK Jr.March 31, 2025 | cnbc.comBiotech stocks tumble on reports FDA's top vaccine regulator to leaveMarch 31, 2025 | reuters.comNovavax, Inc. (NVAX): Among Top High-Risk, High-Reward Growth Stocks To Buy NowMarch 30, 2025 | insidermonkey.comNovavax, Inc. (NVAX): Among Top High-Risk, High-Reward Growth Stocks To Buy NowMarch 30, 2025 | finance.yahoo.com Remove Ads Get Novavax News Delivered to You Automatically Sign up to receive the latest news and ratings for NVAX and its competitors with MarketBeat's FREE daily newsletter. Email Address NVAX Media Mentions By Week NVAX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVAX News Sentiment▼0.590.99▲Average Medical News Sentiment NVAX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVAX Articles This Week▼2010▲NVAX Articles Average Week Remove Ads Get Novavax News Delivered to You Automatically Sign up to receive the latest news and ratings for NVAX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amicus Therapeutics News Ligand Pharmaceuticals News Dynavax Technologies News MannKind News BioCryst Pharmaceuticals News Innoviva News OPKO Health News Celldex Therapeutics News Geron News Myriad Genetics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NVAX) was last updated on 4/13/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredReal Americans Don’t Wait on Wall Street’s Next MoveWhat's happening in the markets right now should concern every freedom-loving American who's worked hard and s...Premier Gold Co | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novavax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Novavax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NVAX Stock Free NVAX Stock Alerts